^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Amplimexon (imexon)

    i
    Associations
    News

    Trials

    Company:
    Amplimed Corp
    Drug class:
    Ribonucleotide reductase inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer (NCT00637247)
    Phase 2
    AmpliMed Corporation
    Completed
    Last update posted :
    03/20/2019
    Initiation :
    04/01/2008
    Primary completion :
    05/01/2010
    Completion :
    06/01/2010
    G6PD
    |
    gemcitabine • Amplimexon (imexon)
    Imexon for Relapsed Follicular and Aggressive Lymphomas (NCT01314014)
    Phase 2
    University of Rochester
    Completed
    Last update posted :
    01/06/2016
    Initiation :
    05/01/2011
    Primary completion :
    03/01/2013
    Completion :
    08/01/2014
    G6PD
    |
    Amplimexon (imexon)